|
OTUD4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.293900E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.023900E-02 |
| Normal-vs-Stage2 |
3.944800E-01 |
| Normal-vs-Stage3 |
1.765790E-01 |
| Normal-vs-Stage4 |
8.109200E-01 |
| Stage1-vs-Stage2 |
5.811600E-01 |
| Stage1-vs-Stage3 |
9.388000E-01 |
| Stage1-vs-Stage4 |
5.090800E-01 |
| Stage2-vs-Stage3 |
6.775400E-01 |
| Stage2-vs-Stage4 |
8.258000E-01 |
| Stage3-vs-Stage4 |
5.995800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.066300E-02 |
| Normal-vs-AfricanAmerican |
1.704440E-01 |
| Normal-vs-Asian |
7.318300E-02 |
| Caucasian-vs-AfricanAmerican |
8.881400E-01 |
| Caucasian-vs-Asian |
5.748400E-01 |
| AfricanAmerican-vs-Asian |
5.233200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.624400E-02 |
| Normal-vs-Female |
4.233000E-01 |
| Male-vs-Female |
3.327000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.399600E-03 |
| Normal-vs-Extreme_Weight |
2.831900E-02 |
| Normal-vs-Obese |
7.810200E-01 |
| Normal-vs-Extreme_Obese |
1.776020E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.746800E-01 |
| Normal_Weight-vs-Obese |
3.456500E-02 |
| Normal_Weight-vs-Extreme_Obese |
6.511000E-01 |
| Extreme_Weight-vs-Obese |
8.097800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.264600E-01 |
| Obese-vs-Extreme_Obese |
4.147200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.888800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.423000E-01 |
| Normal-vs-Age(61-80Yrs) |
7.456600E-03 |
| Normal-vs-Age(81-100Yrs) |
1.119040E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.689800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.410370E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.562320E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.517500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.794090E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.634980E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.578200E-01 |
| Normal-VS-Type2 PRCC |
9.72870000000015E-05 |
| Normal-VS-KIRP CIMP |
3.548600E-01 |
| Normal-VS-Unclassified PRCC |
9.657600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.372730E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.482970E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.558600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.034800E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
5.499700E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
4.029600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.9532999999945E-05 |
| Normal-vs-N1 |
7.523000E-01 |
| Normal-vs-N2 |
9.044800E-01 |
| N0-vs-N1 |
3.518100E-02 |
| N0-vs-N2 |
1.116400E-01 |
| N1-vs-N2 |
9.526000E-01 |
|
|
